Marker Therapeutics (MRKR.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov14

Marker Therapeutics released FY2025 9 Months Earnings on November 13, 2025 (EST), with actual revenue of USD 2.443M and EPS of USD -0.8103

04:00

Marker Therapeutics released FY2025 Q3 earnings on November 13 (EST), actual revenue USD 1.233 M (forecast USD 723 K), actual EPS USD -0.1199 (forecast USD -0.45)

04:00

Aug15

Marker Therapeutics released FY2025 Semi-Annual earnings on August 14, 2025 (EST) with actual revenue of USD 1.21 M and EPS of USD -0.6748

03:00

Marker Therapeutics released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 861.18 K (forecast USD 723 K), actual EPS USD -0.2877 (forecast USD -0.41)

03:00

Jun17

Marker Therapeutics partners with Cellipont to enhance MT-601 T-cell therapy production

12:01

Jun9

Marker Therapeutics Holds 2025 Annual Shareholders' Meeting

20:14